CellWell record HH-13380
Butyrate-Modified Hyaluronic Acid Ameliorates MPTP-Induced Parkinson's Disease via Modulating PINK1/Parkin-Involved Mitophagy and Intestinal Flora.
Sun Y; Cui L; Peng W; Chen R; Guan X; Liu J
Biomacromolecules ยท 2026
In plain language
In a mouse Parkinson's disease model, butyrate-modified hyaluronic acid improved motor behavior test results, promoted PINK1/Parkin-related mitophagy, shifted gut microbiota, and raised short-chain fatty acid levels.
- Studied in
- Animal
Cite this record: https://thecellwell.org/studies/HH-13380
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.